Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study

BACKGROUND: Desensitization with IVIG and rituximab allows acceptable graft survival in sensitized kidney transplant recipients with preexisting donor-specific antibodies (DSAs) and a positive crossmatch. There is little published data reporting the durability of DSA removal in kidney transplant rec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplant Direct
Autors principals: Shaffer, David, Feurer, Irene D., Crowe, Deborah, Schaefer, Heidi
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2016
Matèries:
Kidney Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946491/
https://ncbi.nlm.nih.gov/pubmed/27500255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000570
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars